The effectiveness of intermittent hyperbaric oxygen in relieving drug-induced HIV-associated neuropathy

Journal of the National Medical Association

Volumn 90, Issue 6, 1998, Pages 355-358

  Jordan, Wilbert C ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Human immunodeficiency virus; Hyperbaric oxygen; Substance abuse

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; DRUG COMBINATION; FATIGUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERBARIC OXYGEN; PERIPHERAL NEUROPATHY; TIME; TREATMENT OUTCOME;

ANTI-HIV AGENTS; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FATIGUE; HIV INFECTIONS; HUMANS; HYPERBARIC OXYGENATION; PERIPHERAL NERVOUS SYSTEM DISEASES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0032087561     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Riello M, Myers RA. Hyperbaric oxygen therapy for the treatment of debilitating fatigue associated with HIV/AIDS. JANAC. 1994;4. Abstract.
2. Ginaldi L, Pilotti S. Modification of immune parameters after hyperbaric oxygen treatment in healthy volunteers. Hyperbaric Med. 1991;6:25-31.
3. Le J, Vilcek J. Biology of disease, tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biologic activities. Lab Invest. 1987;56:234-248.
4. Polonis V, Anderson G. Anoxia induces human immunodeficiency virus expression in infected T cell lines. Biol Chem. 1991;266:1421-1424.
5. Bocci V. May hyperbaric oxygenation be useful to patients with AIDS? Journal of Biological Regulation. 1987;201. Letter to the Editor.